Melanoma Clinical Trial

Clinical Trial Finder Melanoma Trials

Study of the Nevisense Device to Assess Atypical Skin Lesions

See Locations Near You

Summary

The purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments done during routine screening for melanoma. Assessing particpants' moles with the Nevisense device may help improve screening methods for the early detection of melanoma in people with atypical mole syndrome.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult patients (> 30 years of age) at the time of the initial study visit.
Patients displaying a phenotype that consists of ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) > 5 mm in diameter. These patients have "atypical mole syndrome", which is a high-risk nevus phenotype and the target patient population in this study.
Patients with at least three clinically stable nevi between 5 and 20 mm in diameter.
Patients (or LAR) who are able to provide informed consent.
Patients with previous total body photography images taken at least 3 years prior

Exclusion Criteria:

Patients without at least three clinically stable nevi between 5 and 20 mm in diameter.
Patients with any electronic implantable devices.
Patients who are pregnant (verbally confirmed with the participant).

Study is for people with:

Melanoma

Estimated Enrollment:

40

Study ID:

NCT04705168

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge New Jersey, 07920, United States
Memorial Sloan Kettering Westchester (Consent only)
Harrison New York, 10604, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

40

Study ID:

NCT04705168

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider